FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate | 1 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Atropine Sulfate | .1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bimatoprost | .1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine | 5 mg/1 mL; 20 mg/1 mL; 1.5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 5 mg/1 mL; 20 mg/1 mL; 1.5 mg/1 mL; .1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride | 50 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride | 25 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride; Tobramycin | 25 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Vancomycin Hydrochloride; Tobramycin | 50 mg/1 mL; 15 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0012 | 71139-0012-1 | Oxytocin | 30 U/500 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-1 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-2 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5330 | 71139-5330-2 | Cefazolin Sodium | 3 g/30 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7087 | 71139-7087-1 | Cefazolin Sodium | 2 g/20 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0190 | 71139-0190-1 | "vasopressin, Unspecified" | 2 U/2 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6643 | 71139-6643-1 | Ephedrine Sulfate | 25 mg/5 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5345 | 71139-5345-2 | Epinephrine; Bupivacaine Hydrochloride | 150 ug/30 mL; 75 mg/30 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5350 | 71139-5350-1 | Epinephrine; Bupivacaine Hydrochloride | 150 ug/30 mL; 150 mg/30 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2500 ug/50 mL | 2023-2 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 1.04 g/1 mL; 123 mg/1 mL; 2.19 g/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-919 | 69374-919-10 | Succinylcholine Chloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-564 | 69374-564-10 | Conivaptan Hydrochloride | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-330 | 69374-330-05 | Albuterol | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-946 | 69374-946-34 | Labetalol Hydrochloride | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-520 | 69374-520-05 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-949 | 69374-949-35 | Lidocaine Hydrochloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 75 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 75 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate; Ketorolac Tromethamine | 5 mg/1 mL; 1 mg/1 mL; 4 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate; Ketorolac Tromethamine | 5 mg/1 mL; 1 mg/1 mL; 4 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | ||||
| "OSRX, Inc.(117108300)" | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 5 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL | 2023-2 | valid | 2026-11-08 |